Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Hyperlane (HYPER) vs Injective (INJ) Price & Performance

Price performance (Past 24H)

Key statistics

Hyperlane vs Injective — how do they compare? Hyperlane trades at Rp1,145 (market cap Rp450,56M, Rp113,38M 24h volume), while Injective trades at Rp82,309 (market cap Rp8,16T, Rp947,87M 24h volume). The key difference: Injective is far larger — about 18110.8× Hyperlane's market cap, and Hyperlane's supply is capped (393,2M / 1B HYPER (40%)) while Injective's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Hyperlane for 31 Days and Injective for 37 Days on average.

HYPERINJ
Market Cap
Rp450,56MRp8,16T
Volume (24h)
Rp113,38MRp947,87M
Circulating Supply
393,2M / 1B HYPER (40%)100M INJ
Typical Hold Time
31 Days37 Days

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Hyperlane

Hyperlane trades at Rp1,118.2 with a market cap of Rp439.51 million, showing bearish technical signals from moving averages but bullish oscillators. The token faces resistance near Rp1,131 with support at Rp1,071. With 40% circulating supply and 31-day average hold time, the project shows moderate network participation. No major protocol updates or ecosystem developments were reported recently.

Overall outlook remains cautious with mixed technical signals. Key opportunities include potential bounce from support levels given bullish oscillator readings. Major risks include low liquidity, bearish trend momentum, and limited circulating supply. Investors should monitor volume patterns and network activity for directional confirmation.

Injective

Injective (INJ) is trading at Rp82,266 with a market cap of Rp8.23 trillion, showing a bearish technical signal driven by moving averages, while oscillators remain neutral. The asset faces resistance near Rp83,795 and finds support at Rp79,595, with on-chain data indicating an average hold time of 37 days. No major protocol upgrades or ecosystem news have been reported recently, keeping fundamental developments quiet.

Overall outlook is cautious due to bearish technicals and lack of positive catalysts. Key opportunities include potential rebounds from support levels, but risks involve high volatility, regulatory uncertainty in crypto markets, and low trading volume depth. Investors should monitor for any ecosystem updates or shifts in market sentiment.

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

HYPER
0% Buy100% Sell
Avg holding period · 31 Days
INJ
100% Buy0% Sell
Avg holding period · 37 Days

Top news

Latest headlines on both assets

About Hyperlane

Hyperlane is an innovative interoperability layer designed to connect the modular blockchain ecosystem. It facilitates seamless communication across different blockchain environments, including Layer 1s, rollups, and app-chains. Created for permissionless deployment, Hyperlane enables developers to easily bridge chains while providing customizable security models tailored to the specific requirements of their applications.

Read more on HYPER

About Injective

Injective enables access to unlimited DeFi markets. Users can create any financial market on Injective's fast, cross-chain, zero gas fee, secure, and fully decentralized exchange protocol. The trading infrastructure of Injective is supported entirely by a central limit order book that integrates the user-friendly interface and speed of centralized exchanges with the transparency of decentralized exchanges. Native token INJ is a scarce asset that used for governance, exchange value capture, liquidity mining, and staking.

Read more on INJ